We are a team of industry veterans passionate about helping MedTech innovators bring life-changing technologies to patients
Our Mission
UnifiMed supports early-stage MedTech founders, executives, and investors navigating U.S. market entry and scale. We operate at the intersection of FDA strategy, clinical evidence, reimbursement pathways, and commercial execution to reduce risk and accelerate adoption.
Our team brings deep regulatory, clinical, and commercial experience, including leadership roles across FDA submissions, reimbursement strategy, clinical operations, and U.S. product launches. We work alongside companies to design integrated strategies that align regulatory decisions with evidence generation, access planning, and downstream commercialization.
Our mission is to ensure innovative medical technologies reach patients by closing the gap between development and real-world adoption. We achieve this through integrated leadership and staffing across regulatory, clinical, reimbursement, and commercial disciplines, embedding experienced operators and specialized teams directly into execution while maintaining alignment to a unified U.S. commercialization strategy.
UnifiMed is a scalable and efficient MedTech ecosystem built to de-risk innovation, accelerate time to market, and deliver measurable outcomes for companies and investors
Our leadership team combines deep experience across regulatory strategy, clinical evidence, reimbursement, and U.S. commercialization
Senior MedTech commercialization leader with extensive experience building US market entry, commercial infrastructure, and cross-functional execution across regulatory, clinical, reimbursement, and sales.
Senior MedTech reimbursement and market access leader with over 25 years of experience spanning Medicare and commercial payer strategy, coverage policy development, coding, and payment implementation across all sites of care.
CVICU nurse and clinical strategist with over 20 years of experience supporting cardiovascular devices through clinical execution, medical affairs, and evidence-driven education.
Senior MedTech commercial leader with decades of experience building and scaling sales organizations for breakthrough cardiovascular and implantable technologies.
Senior regulatory strategist with over 20 years of experience guiding medical device companies through FDA strategy, quality systems, and compliance execution. Founder of Simple Path.
UnifiMed works across the MedTech ecosystem, partnering with organizations at the moments where U.S. commercialization success is most at risk.
MedTech Startups
Early-stage companies developing novel medical technologies. We guide regulatory pathway selection, evidence planning, reimbursement positioning, and commercial strategy to establish a viable U.S. launch foundation.
Established MedTech Companies
Companies with cleared or approved products seeking to refine U.S. strategy, expand indications, improve adoption, or correct misalignment between evidence, reimbursement, and commercial execution.
Private Equity and Venture Capital Firms
Investors managing MedTech portfolios. We support technical diligence, regulatory and reimbursement strategy, clinical and commercial execution, and post-investment value creation.
Clinicians, Researchers, and Inventors
Clinical innovators transitioning technologies from concept through early feasibility, regulatory strategy, and evidence development required for U.S. commercialization.
Global MedTech Companies Entering the US Market
International manufacturers establishing U.S. operations. We provide FDA strategy, reimbursement and coverage planning, clinical execution support, and U.S. go-to-market infrastructure.
Strategic and Industry Partners
Organizations supporting healthcare innovation, including research institutions, providers, and industry groups, where aligned execution strengthens evidence generation and adoption.
Whether you’re a MedTech startup looking for support or a professional wanting to make an impact, we’d love to hear from you.
UnifiMed is a global advisory firm supporting early-stage MedTech founders and executives on their journey to commercialization in the United States. We provide a comprehensive suite of services, including regulatory guidance, market strategy development, financial support through direct investment and access to capital networks, and operational execution.
Our team brings a unique combination of clinical, regulatory, and commercial expertise, having successfully led clinical departments, regulatory and reimbursement activities, and commercial strategies and product launches for several startup and Fortune 500 companies. Leveraging our extensive knowledge and network, we help MedTech innovators achieve sustainable growth and establish a strong foothold in the U.S. healthcare market.
Our mission is to bridge the gap between innovation and patient care by empowering MedTech founders with the access, expertise, resources, and strategic partnerships needed to succeed. By pairing groundbreaking technologies with clinical and commercial expertise, we streamline market entry for our clients and companies. We are dedicated to advancing healthcare by ensuring groundbreaking technologies reach the market, improving outcomes, and enhancing the quality of life for patients across the United States.
UnifiMed is a scalable and efficient MedTech ecosystem designed to de-risk innovative companies, accelerate time to market, and deliver measurable outcomes for both companies and investors.
By integrating regulatory expertise, commercial strategy, and financial support, we create a seamless pathway for MedTech innovators to achieve success while maximizing value and minimizing risk.
UnifiMed partners with a diverse range of stakeholders across the MedTech ecosystem, focusing on early-stage founders, executives, and investors who are driving innovation in healthcare.
Our clients include:
MedTech Startups
Visionary entrepreneurs and early-stage companies seeking to bring groundbreaking medical technologies to market. We provide the expertise and resources needed to navigate regulatory pathways, develop commercialization strategies, and secure funding to accelerate their growth.
Established MedTech Companies
Organizations with proven technologies looking to expand their market presence or optimize their US operations. We help these clients refine their go-to-market strategies, improve operational efficiency, and achieve sustainable growth.
Private Equity and Venture Capital Firms
Investors focused on maximizing the value of their MedTech portfolios. We partner with private equity and venture capital firms to de-risk investments, streamline commercialization efforts, and deliver measurable financial and operational outcomes.
Healthcare Innovators and Inventors
Clinicians, researchers, and inventors with novel technologies seeking support to transition from concept to market-ready solutions. We offer end-to-end guidance, from regulatory compliance to market positioning.
Global MedTech Companies Entering the US Market
International companies aiming to establish a foothold in the U.S. healthcare market. We provide localized expertise to navigate the complex regulatory environment, build connections with key stakeholders, and design effective market-entry strategies.
Strategic Partners and Collaborators
Organizations and institutions aligned with advancing healthcare innovation, including research institutions, healthcare providers, and industry associations. We work collaboratively to enhance the impact of innovative solutions and improve patient outcomes.
By tailoring our services to the unique needs of each client, UnifiMed bridges the gap between innovation and commercialization. Whether it’s navigating regulatory complexities, securing funding, or executing market entry strategies, we provide the strategic support and operational expertise to ensure long-term success. Our client-focused approach ensures that MedTech innovators are empowered to create lasting impacts on healthcare and patient outcomes.
